NCT00019656 2015-04-29Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT00873457 2013-05-27Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDuke UniversityPhase 2 Completed16 enrolled 8 charts